Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Cystic fibrosis - genetics"'
Autor:
Jonathan L. Gillan, Mithil Chokshi, Gareth R. Hardisty, Sara Clohisey Hendry, Daniel Prasca-Chamorro, Nicola J. Robinson, Benjamin Lasota, Richard Clark, Lee Murphy, Moira K. B. Whyte, J. Kenneth Baillie, Donald J. Davidson, Gang Bao, Robert D. Gray
Publikováno v:
Gillan, J L, Chokshi, M, Hardisty, G R, Clohisey Hendry, S, Prasca-Chamorro, D, Robinson, N J, Lasota, B, Clark, R, Murphy, L, Whyte, M K B, Baillie, J K, Davidson, D J, Bao, G & Gray, R D 2023, ' CAGE sequencing reveals CFTR-dependent dysregulation of type I IFN signaling in activated cystic fibrosis macrophages ', Science Advances, vol. 9, no. 21, eadg5128, pp. 1-17 . https://doi.org/10.1126/sciadv.adg5128
An intense, nonresolving airway inflammatory response leads to destructive lung disease in cystic fibrosis (CF). Dysregulation of macrophage immune function may be a key facet governing the progression of CF lung disease, but the underlying mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1d6f49036f9327fdf6f94531d99523
https://www.pure.ed.ac.uk/ws/files/350052675/sciadv.adg5128.pdf
https://www.pure.ed.ac.uk/ws/files/350052675/sciadv.adg5128.pdf
Autor:
Vinícius Buaes Dal'Maso, Lucas Mallmann, Marina Siebert, Laura Simon, Maria Luiza Saraiva-Pereira, Paulo de Tarso Roth Dalcin
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 39, Iss 2, Pp 181-189 (2013)
OBJECTIVE: To evaluate the diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in patients suspected of having mild or atypical cystic fibrosis (CF). METHODS: This was a cross-sectional
Externí odkaz:
https://doaj.org/article/7dd46989eb9e44acbe4b3ca36ebc00cb
Publikováno v:
Biomédica: revista del Instituto Nacional de Salud, Vol 40, Iss 2, Pp 283-295 (2020)
Biomédica, Volume: 40, Issue: 2, Pages: 283-295, Published: 30 JUN 2020
Biomédica
Biomédica, Volume: 40, Issue: 2, Pages: 283-295, Published: 30 JUN 2020
Biomédica
Resumen Introducción. La fibrosis quística es una enfermedad genética de carácter autosómico recesivo clasificada como enfermedad huérfana de alto costo. Objetivo. Determinar la razón de costo-efectividad de la prueba diagnóstica de secuencia
Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia
Autor:
Amatngalim, Gimano D, Rodenburg, Lisa W, Aalbers, Bente L, Raeven, Henriette Hm, Aarts, Ellen M, Sarhane, Dounia, Spelier, Sacha, Lefferts, Juliet W, Silva, Iris Al, Nijenhuis, Wilco, Vrendenbarg, Sacha, Kruisselbrink, Evelien, Brunsveld, Jesse E, van Drunen, Cornelis M, Michel, Sabine, de Winter-de Groot, Karin M, Heijerman, Harry G, Kapitein, Lukas C, Amaral, Magarida D, van der Ent, Cornelis K, Beekman, Jeffrey M, Celbiologie, Sub Cell Biology
Publikováno v:
Life Science Alliance, 5(12):e202101320. Rockefeller University Press
Life Science Alliance, 5(12), 1. Rockefeller University Press
Life Science Alliance, 5(12), 1. Rockefeller University Press
Cystic fibrosis is caused by genetic defects that impair the CFTR channel in airway epithelial cells. These defects may be overcome by specific CFTR modulating drugs, for which the efficacy can be predicted in a personalized manner using 3D nasal-bru
Autor:
Vinciane Saint-Criq, Mahfud A. Ben-Hamida, Mike Althaus, Iram J. Haq, Malcolm Brodlie, C. O'Brien, Chris Ward, Hui Ying Yeoh, Michael A. Gray, Urjita Joshi, Peter van der Sluijs, Aaron Gardner, Bernard Verdon, Stephen Bourke, Matthew F. Thomas, Jennifer Townshend, Ineke Braakman
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology
American Journal of Physiology-Lung Cellular and Molecular Physiology, American Physiological Society, In press, ⟨10.1152/ajplung.00137.2020⟩
American Journal of Physiology-Lung Cellular and Molecular Physiology, 320(2), L288. American Physiological Society
American Journal of Physiology: Lung Cellular and Molecular Physiology
Am J Physiol Lung Cell Mol Physiol 320:L288–L300, 2021
American Journal of Physiology-Lung Cellular and Molecular Physiology, American Physiological Society, In press, ⟨10.1152/ajplung.00137.2020⟩
American Journal of Physiology-Lung Cellular and Molecular Physiology, 320(2), L288. American Physiological Society
American Journal of Physiology: Lung Cellular and Molecular Physiology
Am J Physiol Lung Cell Mol Physiol 320:L288–L300, 2021
Cystic fibrosis (CF) arises from mutations in the CF transmembrane conductance regulator ( CFTR) gene, resulting in progressive and life-limiting respiratory disease. R751L is a rare CFTR mutation that is poorly characterized. Our aims were to descri
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marina Siebert, Vinícius Buaes Dal'Maso, Maria Luiza Saraiva-Pereira, Laura Simon, Paulo de Tarso Roth Dalcin, Lucas Mallmann
Publikováno v:
Jornal Brasileiro de Pneumologia : Publicaça̋o Oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Jornal Brasileiro de Pneumologia, Volume: 39, Issue: 2, Pages: 181-189, Published: APR 2013
Jornal Brasileiro de Pneumologia, Vol 39, Iss 2, Pp 181-189 (2013)
Jornal Brasileiro de Pneumologia v.39 n.2 2013
Jornal Brasileiro de Pneumologia
Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
instacron:SBPT
Jornal Brasileiro de Pneumologia, Volume: 39, Issue: 2, Pages: 181-189, Published: APR 2013
Jornal Brasileiro de Pneumologia, Vol 39, Iss 2, Pp 181-189 (2013)
Jornal Brasileiro de Pneumologia v.39 n.2 2013
Jornal Brasileiro de Pneumologia
Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
instacron:SBPT
OBJECTIVE: To evaluate the diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in patients suspected of having mild or atypical cystic fibrosis (CF). METHODS: This was a cross-sectional
Proceedings of an international workshop held in Sestri Levante (Genoa), Italy, April 9--11, 1990
Autor:
Nathalie Coolen, Virginie Prulière-Escabasse, Pierre-Régis Burgel, Daniel Dusser, Estelle Escudier, André Coste, Yongzheng Wu, Isabelle Fajac, Lhousseine Touqui, Guiti Thévenot, Clémence Martin, Jean-François Papon
Publikováno v:
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2013, 42 (6), pp.1553-1562. ⟨10.1183/09031936.00164212⟩
European Respiratory Journal, 2013, 42 (6), pp.1553-1562. ⟨10.1183/09031936.00164212⟩
European Respiratory Journal, European Respiratory Society, 2013, 42 (6), pp.1553-1562. ⟨10.1183/09031936.00164212⟩
European Respiratory Journal, 2013, 42 (6), pp.1553-1562. ⟨10.1183/09031936.00164212⟩
International audience; Peribronchial angiogenesis may occur in cystic fibrosis and vascular endothelial growth factor (VEGF)-A regulates angiogenesis in airways. Peribronchial vascularity and VEGF-A expression were examined using immunocytochemistry